RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Monthly reportEDA

Egyptian Drug AuthorityMarch 2026

What this register recorded from EDA in March 2026, what other African authorities published in the same month that bears on it, and what we could not read in EDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Egyptian Drug Authority.

What EDA published

11 action(s) recorded: 7 public warning, 4 recall.

ReferenceDateCountryProductBatchesActionClassSource
DEA-EG-2026-0013Mar 2026EGZURCAL1 vial of Powder For Solution For Iv Injection251696Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0014Mar 2026EGAmoxicillin Trihydrate20 % (W.S.P) Doxycycline 20% (W.S.P) Ampicillin Trihydrate 20% (W.S.P) Neobiotic(W.S.P)2401123 · 2402127Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0015Mar 2026EGE-moxclav1gm film coated tablet
Eipico
2503745RecallClass IITier 1 · Regulator-published
DEA-EG-2026-0016Mar 2026EGAdport 1 mg Hard gelatin capsules
Sandoz Egypt Pharma
PM4379 · PC3053RecallClass IITier 1 · Regulator-published
DEA-EG-2026-0017Mar 2026EGEpclusa® 100 mg/400 mgE800532 · 2094-01APublic warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0018Mar 2026EGCiprofar 750 mg303334Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0019Mar 2026EGUnispecta-L258145Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0020Mar 2026EG(Pantogar) Growthpartigar Shampoo001Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0021Mar 2026EGKeppra 500 mg tablets403537Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0022Mar 2026EGVanish10/40 mg FCT
Egyphar
250177RecallClass IITier 1 · Regulator-published
DEA-EG-2026-0023Mar 2026EGMycopedis topical spray
وايزر
2505029RecallClass IIITier 1 · Regulator-published

What other authorities published

Nothing published elsewhere this month joins to EDA by either of the two links this register will draw — a shared event, or a manufacturer EDA has itself named. That is a statement about those two links and not about the month.

What we could not read in EDA’s notices

Our failures on EDA’s coverage, across the whole register rather than this month. Published because a report that told an authority only what it was missing would be an audit sent by someone with no standing to conduct one.

  • 336 record(s) held from EDA in total
  • 5 carry no publication date we could read
  • 43 name neither a batch nor a stated reason
  • 247 name no manufacturer
  • 5 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
  • 0 have no archived copy of the original notice

Each of these is something EDA published and this register did not capture, or captured incompletely. None of them is a failure by EDA.

Correcting this

Anything on this page that is wrong about Egyptian Drug Authority can be corrected by Egyptian Drug Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.

Write to notices@drugeyeafrica.org. Corrections to existing records are logged and published on the corrections page; a superseded record keeps its URL and points forward to the one that replaced it.

Every month for EDA · Egypt · The authorities we read · How this register’s coverage is assessed